Anonymous ID: 463973 Sept. 5, 2021, 3:19 a.m. No.14524503   🗄️.is 🔗kun   >>4548 >>4553

Screening

You will have a Screening Visit to check if you are eligible to enroll in this study. The Screening

Visit may be combined with the first study vaccination visit. If it is a separate visit, it will take

about 60 minutes and will include:

• Reviewing, signing and dating the consent form

• Collecting information about your medical and mental health history, medications (and

for women birth control), and vaccination history

• A physical exam if needed

• Measuring height and weight

Women who can become pregnant must agree to use an acceptable method of birth control from

at least 30 days before the first study vaccination through 60 days after the last study vaccination.

Acceptable birth control methods include abstinence from sexual activity that could lead to

pregnancy, monogamous relationship with a partner who has had a vasectomy at least six months

ago, successful Essure® placement (permanent, non-surgical, non-hormonal sterilization),

intrauterine devices (IUDs), and hormonal methods, including the birth control patch, shot

(Depo-Provera), pills, the vaginal ring (NuvaRing), and the contraceptive implant (Nexplanon).

 

Soooo… this is one of the clinical tests going now?

Anonymous ID: 463973 Sept. 5, 2021, 3:36 a.m. No.14524536   🗄️.is 🔗kun

'''Trial record 34 of 251 for: COVID-19 | NIH, U.S. Fed

Previous Study | Return to List | Next Study

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

 

ClinicalTrials.gov Identifier: NCT04785144

Recruitment Status : Active, not recruiting

First Posted : March 5, 2021

Last Update Posted : August 19, 2021

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator:

ModernaTX, Inc.

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

 

https://clinicaltrials.gov/ct2/show/NCT04785144?cond=COVID-19&fund=01&draw=2&rank=34

 

Check this shit out.

Anonymous ID: 463973 Sept. 5, 2021, 3:47 a.m. No.14524555   🗄️.is 🔗kun   >>4568 >>4578

>>14524546

We're supposed to be getting paid for testing this shit without jumping through hoops, but given they're desire to make us go to therapy, I'm pretty much for gainst signing anything.

 

''National Institutes of Health (NIH)/Division of Microbiology and Infectious Diseases (DMID) /

Protocol Number 21-0002 Page 17 of 26

«PiFullName» Advarra IRB Approved Version 5 Apr 2021 Revised «PIApprovalDate»''

C

 

Compensation for Participation

«Compensation»

You will be paid up to a total of $xx.xx if you complete this study. You will be paid for the visits

you complete according to the following schedule:

• $xx.xx for Visits xxx.

• $xx.xx for Visits xxx.

• $xx.xx for Visits xxx.

If you do not complete the study, for any reason, you will be paid for each study visit you do

complete.

You will be paid _____ [“after each visit,” “annually,” “bi-weekly,” etc.]

If you have any questions regarding your compensation for participation, please contact the study

staff.

[OR]

You will not receive any monetary compensation for your participation in this study.

You will not share in the commercial profit, if this study or your samples provided for research

lead to a licensed product.''

Anonymous ID: 463973 Sept. 5, 2021, 3:56 a.m. No.14524569   🗄️.is 🔗kun

>>14524548

 

Yeah, but the web actually says when they end, and what to expect. That had been my biggest issue with this shit. Fucking gatekeepers.

 

Primary Outcome Measures  :Number of Participants with First Occurrence of Molecularly Confirmed Moderate to Severe/Critical Coronavirus Disease (COVID-19) with Seronegative Status [ Time Frame: 14 Days after double-blind vaccination (Day 15) to end of study (2 years and 1 month) ]

 

Moderate defined as one sign or symptom from a list of signs and symptoms, such as respiratory rate greater than or equal to (>=) 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms from a list of sign and symptoms or severe COVID-19 defined in FDA guidance.

 

https://clinicaltrials.gov/ct2/show/NCT04505722?cond=COVID-19&locn=Tennessee&draw=2&rank=44

Anonymous ID: 463973 Sept. 5, 2021, 4:02 a.m. No.14524583   🗄️.is 🔗kun

>>14524558

 

Nah. I think I'll go here instead.

 

https://www.federalregister.gov/documents/2016/09/21/2016-22129/clinical-trials-registration-and-results-information-submission

 

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/civil-money-penalties-relating-clinicaltrialsgov-data-bank

 

https://www.regulations.gov/document/FDA-2018-D-0787-0001

 

Interview coming up soon guys. Get ready.

Anonymous ID: 463973 Sept. 5, 2021, 4:12 a.m. No.14524604   🗄️.is 🔗kun   >>4607 >>4701 >>4704 >>4725

>>14524590

 

Start here, anon.

 

National Vaccine Injury Compensation Program

 

 

COVID-19 Claims

 

For claims associated with the COVID-19 vaccine or other COVID-19 related countermeasures, please file your Request for Benefits with the Countermeasures Injury Compensation Program.

 

Vaccines save lives by preventing disease.

 

Most people who get vaccines have no serious problems. Vaccines, like any medicines, can cause side effects, but most are very rare and very mild. Some health problems that follow vaccinations are not caused by vaccines.

 

In very rare cases, a vaccine can cause a serious problem, such as a severe allergic reaction.  

 

In these instances, the National Vaccine Injury Compensation Program (VICP) may provide financial compensation to individuals who file a petition and are found to have been injured by a VICP-covered vaccine. Even in cases in which such a finding is not made, petitioners may receive compensation through a settlement. 

 

How does the VICP work?

 

The National Vaccine Injury Compensation Program is a no-fault alternative to the traditional legal system for resolving vaccine injury petitions.

 

It was created in the 1980s, after lawsuits against vaccine companies and health care providers threatened to cause vaccine shortages and reduce U.S. vaccination rates, which could have caused a resurgence of vaccine preventable diseases.

 

Any individual, of any age, who received a covered vaccine and believes he or she was injured as a result, can file a petition. Parents, legal guardians and legal representatives can file on behalf of children, disabled adults, and individuals who are deceased.

 

What is the process?An individual files a petition with the U.S. Court of Federal Claims.The U.S. Department of Health and Human Services medical staff reviews the petition, determines if it meets the medical criteria for compensation and makes a preliminary recommendation.The U.S. Department of Justice develops a report that includes the medical recommendation and legal analysis and submits it to the Court.The report is presented to a court-appointed special master, who decides whether the petitioner should be compensated, often after holding a hearing in which both parties can present evidence. If compensation is awarded, the special master determines the amount and type of compensation.The Court orders the U.S. Department of Health and Human Services to award compensation. Even if the petition is dismissed, if certain requirements are met, the Court may order the Department to pay attorneys' fees and costs. 

 

The special master's decision may be appealed and petitioners who reject the decision of the court (or withdraw their petitions within certain timelines) may file a claim in civil court against the vaccine company and/or the health care provider who administered the vaccine.

 

Disclaimer

 

The content of this website reflects the current thinking of the United States Department of Health and Human Services on the topics addressed and does not create or confer any rights for or on any person and does not operate to bind the Department or the public. The ultimate decision about the scope of the statutes authorizing the VICP is within the authority of the United States Court of Federal Claims, which is responsible for resolving petitions for compensation under the VICP.

 

If you have additional questions, call: 1-800-338-2382 or email: vaccinecompensation@hrsa.gov.

 

https://www.hrsa.gov/vaccine-compensation/index.html

Anonymous ID: 463973 Sept. 5, 2021, 4:16 a.m. No.14524610   🗄️.is 🔗kun

>>14524607

 

Does for me. I got the Jeb from a cop violating my 4th amendment right to hit me with it.

 

WHO benefits the most? It's always been about the technotrannies.